(Q43539821)

24 November 2017

Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells (English)

1 reference

24 November 2017

0 references

1

1 reference

24 November 2017

O Grobe

2

1 reference

24 November 2017

A Sieke

3

1 reference

24 November 2017

M L Kruse

4

1 reference

24 November 2017

U R Fölsch

5

1 reference

24 November 2017

W E Schmidt

6

1 reference

24 November 2017

H Schäfer

7

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

24 November 2017

1 reference

24 November 2017

20

1 reference

24 November 2017

69-76

1 reference

24 November 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1204061

24 November 2017

0 references

cites work

Control of apoptosis by Rel/NF-kappaB transcription factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

Regulation of a novel immediate early response gene, IEX-1, in keratinocytes by 1alpha,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

A role of cyclin G in the process of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

Genomic organization, promoter cloning, and chromosomal localization of the Dif-2 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

Role of NF-kappaB in the apoptotic-resistant phenotype of keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

Aberrant rel/nfkb genes and activity in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

Role of NF-κB in p53-mediated programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

The putative apoptosis inhibitor IEX-1L is a mutant nonspliced variant of p22(PRG1/IEX-1) and is not expressed in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFkappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

Role of protein tyrosine phosphorylation in etoposide-induced apoptosis and NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

INK4 cell cycle inhibitors direct transcriptional inactivation of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

7 January 2021

NF-kappaB regulates Fas/APO-1/CD95- and TCR- mediated apoptosis of T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

7 January 2021

A matter of life and cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

7 January 2021

Repression of NF-kappaB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

7 January 2021

The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

7 January 2021

The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

7 January 2021

NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

7 January 2021

Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

7 January 2021

Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204061

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204061

1 reference

Dimensions Publication ID

24 November 2017

0 references

1 reference